Skip to main content

3 Result(s)

within L Agnelli Remove this filter

and
Your search also matched 8 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo

Include preview-only content

  1. Article

    Open Access

    Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma

    Papillary thyroid cancer (PTC) is the most frequent thyroid tumor. The tissue inhibitor of metalloproteinase-3 (TIMP3) gene encodes a matrix metalloproteinases inhibitor that exerts a tumor suppressor role in ...

    M. Mazzoni, K. Todoerti, L. Agnelli, E. Minna, S. Pagliardini… in Cancer Cell International (2022)

    Download PDF (2791 KB) View Article

  2. Article

    Open Access

    lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

    Long non-coding RNAs (lncRNAs) represent a novel class of functional RNA molecules with an important emerging role in cancer. To elucidate their potential pathogenetic role in chronic lymphocytic leukemia (CLL...

    D Ronchetti, M Manzoni, L Agnelli, C Vinci, S Fabris, G Cutrona… in Blood Cancer Journal (2016)

    Download PDF (1643 KB) View Article

  3. Article

    Open Access

    The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

    Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now e...

    D Ronchetti, K Todoerti, G Tuana, L Agnelli, L Mosca, M Lionetti… in Blood Cancer Journal (2012)

    Download PDF (1664 KB) View Article